| Alicia Perry, PHD | |
|
28311 N Main St, Ste 100, Daphne, AL 36526-7074 | |
| (251) 625-6233 | |
| (251) 625-1482 |
| Full Name | Alicia Perry |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 28311 N Main St, Daphne, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306848361 | NPI | - | NPPES |
| 293890 | Other | MD | MAMSI |
| 51534800 | Other | AL | BCBSOF AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC2200X | Psychologist - Clinical Child & Adolescent | 3665 (Maryland) | Primary |
| 103TC0700X | Psychologist - Clinical | 1394 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alicia Perry, PHD 11541 County Road 1, Fairhope, AL 36532-5943 Ph: (251) 625-6233 | Alicia Perry, PHD 28311 N Main St, Ste 100, Daphne, AL 36526-7074 Ph: (251) 625-6233 |
News Archive
Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
Obesity is a major disease burden in all societies and needs to be prevented early in life. New approaches are eagerly sought and absolutely necessary. This new volume presents a wealth of information on childhood and adolescent obesity, from causes and consequences to societal aspects and prevention of obesity as well as its management.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced top line results from its randomized, double-blind, placebo-controlled, Phase 2b clinical trial of Synavive in rheumatoid arthritis.
EpiCept Corporation announced today that it has established an at-the-market program through which it may sell, from time to time and at its sole discretion, shares of its common stock having an aggregate offering price of up to $15 million. Maxim Group LLC is acting as sales agent on the program.
Walgreens, the nation's largest drugstore chain, and global health care leader Heritage Provider Network, along with its Arizona operating affiliate Arizona Priority Care, today announced a clinical care collaboration agreement.
› Verified 2 days ago
Mr. Erik Paul Goldschmidt, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 25833 State Highway 181 Ste C, Daphne, AL 36526 Phone: 251-861-1313 | |
Katherine Penry, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1203 Us Highway 98, Unit 3b, Daphne, AL 36526 Phone: 504-780-1702 Fax: 504-780-1705 | |
Elizabethann Moore, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 27625 Us Highway 98, Building A, Daphne, AL 36526 Phone: 251-626-7959 Fax: 251-626-6122 |